CTLA4-Ig prolongs survival of microencapsulated neonatal porcine islet xenografts in diabetic NOD mice.

[1]  P. Linsley,et al.  CTLA4-Ig prolongs survival of microencapsulated rabbit islet xenografts in spontaneously diabetic Nod mice. , 1996, Transplantation proceedings.

[2]  G. Korbutt,et al.  Large-scale isolation of viable porcine neonatal islet cell (NIC) aggregates. , 1995, Transplantation Proceedings.

[3]  E. Satyaraj,et al.  Induction of tolerance in freshly isolated alloreactive T cells by activated T cell stimulators is not due to the absence of CD28-B7 interaction. , 1995, Journal of immunology.

[4]  J. Bluestone,et al.  Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse , 1995, The Journal of experimental medicine.

[5]  P. Albert,et al.  Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. , 1995, Journal of immunology.

[6]  M. Jenkins.  The ups and downs of T cell costimulation. , 1994, Immunity.

[7]  P. Linsley,et al.  Transplantation tolerance induced by CTLA4-Ig. , 1994, Transplantation.

[8]  A. Stall,et al.  NOD mouse peritoneal cellular response to poly-L-lysine-alginate microencapsulated rat islets. , 1994, Transplantation proceedings.

[9]  R. Flavell,et al.  The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. , 1994, Immunity.

[10]  C. Janeway,et al.  Signals and signs for lymphocyte responses , 1994, Cell.

[11]  P. Linsley,et al.  Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. , 1993, Science.

[12]  D. Nathan,et al.  Long-term complications of diabetes mellitus. , 1993, The New England journal of medicine.

[13]  Robertson Rp.  Seminars in medicine of the Beth Israel Hospital, Boston: Pancreatic and islet transplantation for diabetes--cures or curiosities? , 1992 .

[14]  G. Freeman,et al.  Murine B7 antigen provides a sufficient costimulatory signal for antigen-specific and MHC-restricted T cell activation. , 1992, Journal of immunology.

[15]  C. Janeway,et al.  Co‐stimulation of murine CD4 T cell growth: cooperation between B7 and heat‐stable antigen , 1992, European journal of immunology.

[16]  P. Linsley,et al.  Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. , 1992, Science.

[17]  J. Allison,et al.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones , 1992, Nature.

[18]  H. Auchincloss,et al.  EVIDENCE THAT MULTIPLE DEFECTS IN CELL‐SURFACE MOLECULE INTERACTIONS ACROSS SPECIES DIFFERENCES ARE RESPONSIBLE FOR DIMINISHED XENOGENEIC T CELL RESPONSES1 , 1992, Transplantation.

[19]  J. Platt,et al.  The barrier to xenotransplantation. , 1991, Transplantation.

[20]  V. D’Agati,et al.  Prolonged functional survival of rat-to-NOD mouse islet xenografts by ultraviolet-B (UV-B) irradiation plus microencapsulation of donor islets. , 1991, Transplantation proceedings.

[21]  R. Pierson,et al.  Xenogeneic proliferation and lymphokine production are dependent on CD4+ helper T cells and self antigen-presenting cells in the mouse , 1990, The Journal of experimental medicine.

[22]  V. D’Agati,et al.  The role of CD4+ helper T cells in the destruction of microencapsulated islet xenografts in nod mice. , 1990, Transplantation.

[23]  B. Hering,et al.  Current Status of Clinical Islet Transplantation , 1988, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[24]  H. Auchincloss.  Xenogeneic transplantation. A review. , 1988, Transplantation.

[25]  P. Lacy,et al.  An Improved Method for the Isolation of Islets from the Beef Pancreas , 1982, Diabetes.